Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vivid Seats (SEAT) Cash & Equivalents (2019 - 2026)

Vivid Seats has reported Cash & Equivalents over the past 8 years, most recently at $144.2 million for Q1 2026.

  • For Q1 2026, Cash & Equivalents fell 28.17% year-over-year to $144.2 million; the TTM value through Mar 2026 reached $144.2 million, down 28.17%, while the annual FY2025 figure was $103.3 million, 57.77% down from the prior year.
  • Cash & Equivalents for Q1 2026 was $144.2 million at Vivid Seats, up from $103.3 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $314.3 million in Q1 2022 and troughed at $103.3 million in Q4 2025.
  • A 5-year average of $220.2 million and a median of $240.4 million in 2024 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: surged 84.73% in 2024 and later tumbled 57.77% in 2025.
  • Year by year, Cash & Equivalents stood at $252.3 million in 2022, then tumbled by 47.51% to $132.4 million in 2023, then surged by 84.73% to $244.6 million in 2024, then tumbled by 57.77% to $103.3 million in 2025, then skyrocketed by 39.55% to $144.2 million in 2026.
  • Business Quant data shows Cash & Equivalents for SEAT at $144.2 million in Q1 2026, $103.3 million in Q4 2025, and $145.7 million in Q3 2025.